Search research articles
Contact Us
Filters
Showing results (471-480 of 590) with videos related to
Page
of 59
Sort By:
Experimental Neurology
|
July 1, 2008
Toll-like receptor-4 mediates neuronal apoptosis induced by amyloid beta-peptide and the membrane lipid peroxidation product 4-hydroxynonenal
Sung-Chun Tang, Justin D Lathia, Pradeep K Selvaraj, et al.
Journal of Alzheimer'S Disease : JAD
|
September 18, 2010
The KATP channel activator diazoxide ameliorates amyloid-β and tau pathologies and improves memory in the 3xTgAD mouse model of Alzheimer's disease
Dong Liu, Michael Pitta, Jong-Hwan Lee, et al.
Journal of Neurochemistry
|
March 21, 2002
A link between maze learning and hippocampal expression of neuroleukin and its receptor gp78
Yongquan Luo, Jeffery M Long, Chengbiao Lu, et al.
Experimental Neurology
|
November 18, 2008
Diminished iron concentrations increase adenosine A(2A) receptor levels in mouse striatum and cultured human neuroblastoma cells
Seema Gulyani, Christopher J Earley, Simonetta Camandola, et al.
Vaccine
|
January 18, 2012
DNA immunization with HBsAg-based particles expressing a B cell epitope of amyloid β-peptide attenuates disease progression and prolongs survival in a mouse model of Alzheimer's disease
Purevdorj B Olkhanud, Mohammed Mughal, Koichi Ayukawa, et al.
Neuromolecular Medicine
|
April 1, 2003
Autoantibodies to amyloid beta-peptide (Abeta) are increased in Alzheimer's disease patients and Abeta antibodies can enhance Abeta neurotoxicity: implications for disease pathogenesis and vaccine development
Avindra Nath, Elizabeth Hall, Marnia Tuzova, et al.
Neuron
|
February 15, 2011
Activity-induced Notch signaling in neurons requires Arc/Arg3.1 and is essential for synaptic plasticity in hippocampal networks
Lavinia Alberi, Shuxi Liu, Yue Wang, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
May 26, 2010
Transferrin fusion technology: a novel approach to prolonging biological half-life of insulinotropic peptides
Byung-Joon Kim, Jie Zhou, Bronwen Martin, et al.
Glia
|
May 8, 2013
Evidence for miR-181 involvement in neuroinflammatory responses of astrocytes
Emmette R Hutchison, Elisa M Kawamoto, Dennis D Taub, et al.
ACS Pharmacology & Translational Science
|
August 10, 2019
Incretin Mimetics as Rational Candidates for the Treatment of Traumatic Brain Injury
Elliot J Glotfelty, Thomas Delgado, Luis B Tovar-Y-Romo, et al.
Page
of 59
Search research articles
Search
Showing results (471-480 of 590) with videos related to
Sort By:
Page
of 59
Experimental Neurology
|
July 1, 2008
Toll-like receptor-4 mediates neuronal apoptosis induced by amyloid beta-peptide and the membrane lipid peroxidation product 4-hydroxynonenal
Sung-Chun Tang, Justin D Lathia, Pradeep K Selvaraj, et al.
Journal of Alzheimer'S Disease : JAD
|
September 18, 2010
The KATP channel activator diazoxide ameliorates amyloid-β and tau pathologies and improves memory in the 3xTgAD mouse model of Alzheimer's disease
Dong Liu, Michael Pitta, Jong-Hwan Lee, et al.
Journal of Neurochemistry
|
March 21, 2002
A link between maze learning and hippocampal expression of neuroleukin and its receptor gp78
Yongquan Luo, Jeffery M Long, Chengbiao Lu, et al.
Experimental Neurology
|
November 18, 2008
Diminished iron concentrations increase adenosine A(2A) receptor levels in mouse striatum and cultured human neuroblastoma cells
Seema Gulyani, Christopher J Earley, Simonetta Camandola, et al.
Vaccine
|
January 18, 2012
DNA immunization with HBsAg-based particles expressing a B cell epitope of amyloid β-peptide attenuates disease progression and prolongs survival in a mouse model of Alzheimer's disease
Purevdorj B Olkhanud, Mohammed Mughal, Koichi Ayukawa, et al.
Neuromolecular Medicine
|
April 1, 2003
Autoantibodies to amyloid beta-peptide (Abeta) are increased in Alzheimer's disease patients and Abeta antibodies can enhance Abeta neurotoxicity: implications for disease pathogenesis and vaccine development
Avindra Nath, Elizabeth Hall, Marnia Tuzova, et al.
Neuron
|
February 15, 2011
Activity-induced Notch signaling in neurons requires Arc/Arg3.1 and is essential for synaptic plasticity in hippocampal networks
Lavinia Alberi, Shuxi Liu, Yue Wang, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
May 26, 2010
Transferrin fusion technology: a novel approach to prolonging biological half-life of insulinotropic peptides
Byung-Joon Kim, Jie Zhou, Bronwen Martin, et al.
Glia
|
May 8, 2013
Evidence for miR-181 involvement in neuroinflammatory responses of astrocytes
Emmette R Hutchison, Elisa M Kawamoto, Dennis D Taub, et al.
ACS Pharmacology & Translational Science
|
August 10, 2019
Incretin Mimetics as Rational Candidates for the Treatment of Traumatic Brain Injury
Elliot J Glotfelty, Thomas Delgado, Luis B Tovar-Y-Romo, et al.
Page
of 59